(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -11.35%27.34B | -13.40%113.5B | -16.42%84.29B | -16.32%58.83B | -11.69%30.84B | -3.71%131.07B | -6.71%100.85B | -2.78%70.29B | 9.77%34.93B | 34.90%136.12B |
Operating income | -11.35%27.34B | -13.40%113.5B | -16.42%84.29B | -16.32%58.83B | -11.69%30.84B | -3.71%131.07B | -6.71%100.85B | -2.78%70.29B | 9.77%34.93B | 34.90%136.12B |
Operating expenses | 6.67%-28.29B | 10.92%-114.04B | 14.06%-84.54B | 11.48%-58.97B | 6.43%-30.31B | -4.26%-128.02B | -3.00%-98.37B | -4.80%-66.61B | -12.37%-32.39B | -30.20%-122.79B |
Gross profit | -276.78%-944M | -117.54%-535M | -109.96%-247M | -103.83%-141M | -78.93%534M | -77.12%3.05B | -80.31%2.48B | -57.92%3.68B | -15.28%2.53B | 102.25%13.33B |
Selling expenses | 3.10%-125M | -4.67%-628M | -1.33%-456M | 6.80%-288M | -11.21%-129M | -0.67%-600M | 1.75%-450M | -3.34%-309M | 5.69%-116M | -20.16%-596M |
Administrative expenses | 11.91%-281M | -30.12%-1.69B | -30.15%-1.24B | -14.57%-755M | -1.27%-319M | 12.59%-1.3B | 14.31%-952M | 13.97%-659M | 3.37%-315M | -11.74%-1.49B |
Research and development expenses | 40.30%-80M | 32.32%-492M | 36.81%-357M | 37.97%-245M | 36.79%-134M | -13.59%-727M | -40.90%-565M | -35.74%-395M | -54.74%-212M | -53.48%-640M |
Profit from asset sales | 0.00%25M | -93.75%1M | ---- | 56.25%25M | 56.25%25M | -69.23%16M | 720.00%41M | 1,500.00%16M | 1,500.00%16M | 550.00%52M |
Revaluation surplus | 400.00%30M | -75.68%45M | -72.92%52M | -59.85%53M | -116.13%-10M | 384.62%185M | 334.15%192M | 226.92%132M | 321.43%62M | -261.11%-65M |
-Changes in the fair value of other assets | 400.00%30M | -75.68%45M | -72.92%52M | -59.85%53M | -116.13%-10M | 384.62%185M | 334.15%192M | 226.92%132M | 321.43%62M | -261.11%-65M |
Impairment and provision | -211.11%-80M | -128.86%-116M | -98.53%6M | -90.15%45M | -81.20%72M | 201.52%402M | 146.67%407M | 339.42%457M | 1,640.91%383M | -9.09%-396M |
-Other impairment is provision | -211.11%-80M | -128.86%-116M | -98.53%6M | -90.15%45M | -81.20%72M | 201.52%402M | 146.67%407M | 339.42%457M | 1,640.91%383M | -9.09%-396M |
Special items of operating profit | 43.04%113M | 13.89%369M | 11.66%249M | 4.17%125M | 68.09%79M | -12.20%324M | -35.17%223M | -47.14%120M | -46.59%47M | 33.21%369M |
Operating profit | -1,488.78%-1.56B | -1,546.47%-3.89B | -587.82%-2.64B | -164.09%-1.6B | -104.58%-98M | -97.17%269M | -94.69%542M | -64.45%2.5B | -4.20%2.14B | 191.93%9.51B |
Financing cost | 22.22%-56M | 47.02%-258M | 50.56%-219M | 44.04%-155M | 23.40%-72M | 0.81%-487M | -2.55%-443M | 12.62%-277M | 55.02%-94M | 36.81%-491M |
Special items of earning before tax | 20.00%-12M | 113.73%7M | 83.33%-6M | 16.67%-15M | 75.00%-15M | 20.31%-51M | 47.83%-36M | 18.18%-18M | -233.33%-60M | 18.99%-64M |
Earning before tax | -778.38%-1.63B | -1,439.78%-4.14B | -4,653.97%-2.87B | -180.37%-1.77B | -109.31%-185M | -103.00%-269M | -99.35%63M | -67.05%2.21B | -1.05%1.99B | 272.83%8.96B |
Tax | -162.50%-25M | 125.80%919M | 413.25%775M | 192.21%438M | 108.00%40M | 120.75%407M | 107.05%151M | 67.67%-475M | 0.00%-500M | -381.82%-1.96B |
After-tax profit from continuing operations | -1,037.93%-1.65B | -2,435.51%-3.22B | -1,078.50%-2.09B | -177.12%-1.34B | -109.74%-145M | -98.03%138M | -97.17%214M | -66.88%1.73B | -1.39%1.49B | 250.60%7B |
Earning after tax | -1,037.93%-1.65B | -2,435.51%-3.22B | -1,078.50%-2.09B | -177.12%-1.34B | -109.74%-145M | -98.03%138M | -97.17%214M | -66.88%1.73B | -1.39%1.49B | 250.60%7B |
Minority profit | 75.00%7M | 13.33%34M | 0.00%21M | -26.67%11M | -33.33%4M | -11.76%30M | -12.50%21M | -11.76%15M | -33.33%6M | 88.89%34M |
Profit attributable to shareholders | -1,012.08%-1.66B | -3,115.74%-3.26B | -1,195.85%-2.12B | -178.44%-1.35B | -110.05%-149M | -98.45%108M | -97.44%193M | -67.06%1.72B | -1.20%1.48B | 252.07%6.96B |
Basic earnings per share | -1,006.25%-0.177 | -3,254.55%-0.347 | -1,171.43%-0.225 | -178.57%-0.143 | -110.13%-0.016 | -98.51%0.011 | -97.38%0.021 | -67.15%0.182 | -0.63%0.158 | 252.38%0.74 |
Diluted earnings per share | -941.18%-0.177 | -3,254.55%-0.347 | -1,171.43%-0.225 | -178.57%-0.143 | -111.04%-0.017 | -98.47%0.011 | -97.33%0.021 | -66.67%0.182 | -2.53%0.154 | 263.64%0.72 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (special general partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data